In 2017, Pfizer's partnership with Corning Incorporated introduced

[sumonasumonakha.tu1]

Pfizer's acquisition of Wyeth in 2009 marked a turning point for the company, as it became a leader in a broad range of products and therapies that have touched the lives of countless patients and consumers worldwide.

In 2013, Pfizer announced an ambitious plan to split the company into two publicly traded entities, one focused on advanced medicine development and the other on product development. As part of this restructuring, Pfizer spun off its animal health business, Zoetis, into a separate publicly traded company.

The company’s growth continued in 2014, when Pfizer acquired Baxter International Inc.’s $635 student data million portfolio of marketed vaccines and a portion of Baxter’s Orth, Austria, manufacturing facility. The 2015 acquisition of Hospira added a growing revenue stream and growth platform to Pfizer’s Global Established Pharmaceuticals (GEP) business.

Pfizer's drug discovery collaboration with IBM Watson in 2016 was also a major milestone in the company's journey to advance immuno-oncology research.

Corning Valor Glass, a revolutionary pharmaceutical glass packaging solution that modernized pharmaceutical packaging and improved drug safety.